Purchases and Sales Made in Q3 2023 in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during Q3 2023. The information is specifically focused on institutions that hold shares of CRISPR Therapeutics AG.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-213K- 49.25% |
$9.68M - $12.6M
|
220K
$8.91M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-321K- 70.25% |
$14.6M - $18.9M
|
136K
$5.51M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-667KClosed |
$30.3M - $39.3M
|
0
$0
|